Skip to content

Prostate Cancer E-Health-Tutorial

Prostate Cancer E-Health-Tutorial (PROCET): Multicenter, One-armed Intervention Study to Evaluate an Online Tutorial for Patients With Localized Prostate Cancer

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02503748
Acronym
PROCET
Enrollment
53
Registered
2015-07-21
Start date
2015-07-31
Completion date
2017-02-15
Last updated
2017-04-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prostate Cancer

Brief summary

In a participatory process involving urologists and former patients, the project team has developed an online information system (tutorial) for patients with localized prostate cancer. In this field test, relevant outcomes are measured and the tutorial will be tested for its clinical applicability.

Detailed description

Prostate cancer is the most common cancer in men: In Switzerland, every year about 6,000 men are diagnosed with prostate cancer. Men with prostate cancer at an early stage are confronted with a difficult decision: they are faced with different treatment alternatives, each with its own advantages and disadvantages. That is why a comprehensive information delivery and processing is extremely important for patients to make an informed decision. Therefore, an online platform has been developed in collaboration with urologists and former patients. This online platform is designed to cover the individual information needs of patients with early prostate cancer. Additionally, the software aims at facilitating cooperation between patients and doctors and at increasing the satisfaction of patients with their treatment decision. In this study, the online platform will now to be tested in clinical practice, and data will be collected for the benefit of the platform: Can the online platform actually satisfy the indivudal information needs, facilitate the therapy decision and support the cooperation between doctors and patients?

Interventions

website informing about treatment options in localized prostate cancer

Sponsors

Zurich University of Applied Sciences
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Eligibility

Sex/Gender
MALE
Age
No minimum to 75 Years
Healthy volunteers
No

Inclusion criteria

Medical Inclusion Criteria: * tumor stage: clinical stage T1 or T2 * PSA level \<20 (PSA = Prostata-specific antigen) * Gleason score \<8 * age ≤ 75 years * Assumed life expectancy ≥ 10 years Other inclusion criteria due to the study design and the type of intervention are the following: * patients have to be diagnosed in one of the trial sites * Internet-enabled device in the patient's household / basal user knowledge of this device * signing of the consent form

Exclusion criteria

* Impaired judgment * Insufficient ability to read and understand German * Emotional problems

Design outcomes

Primary

MeasureTime frameDescription
information needs (own scale)4 monthsquestionnaire developed in line with contents of the online tutorial

Secondary

MeasureTime frame
Decision Quality: decisional conflict (Decisional Conflict Scale)1 month
Decision Quality: decision regret (Decision Regret Scale)4 months
Role in decision making: Preferred Role (Preferred Role in Decision Making Scale)1 month
Role in decision making: Actual Role (Actual Role in Decision Making Scale)4 months
Preparation for Decision Making (Preparation for Decision Making Scale)1 month

Countries

Switzerland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026